RD

Reena Devi

Active Director Director DIN 06638475
DIN 06638475 First appointment Aug 2013 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2013
Shareholding value •••• Premium profile

About Reena Devi

Data last updated:

Reena Devi is a Director at Solvmed Pharmaceuticals Private Limited (since 2013). The company operates in Trading. Solvmed Pharmaceuticals Private Limited reported revenue of ₹1.05 Cr (FY 2025).

DIN 06638475
Primary Designation Director
Industry Trading
First Appointment 14 Aug 2013
Oldest Company Age 13 yrs
Largest company Solvmed Pharmaceuticals Private Limited · ₹1.05 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Aug 20132013₹1.05 Cr (FY 2025)Active

Board colleagues of Reena Devi

NameDINCompanyDesignation
Babloo Kumar03302674Solvmed Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Solvmed Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Reena Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Reena Devi

Reena Devi currently holds 1 directorship: Solvmed Pharmaceuticals Private Limited (Director, since 14 Aug 2013, revenue ₹1.05 Cr (FY 2025)).

Reena Devi was first appointed on 14 Aug 2013 as Director at Solvmed Pharmaceuticals Private Limited.

The current boards of Reena Devi's companies include Babloo Kumar (Solvmed Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available